Self-Monitoring Blood Glucose System-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Self-Monitoring Blood Glucose System-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Self-Monitoring Blood Glucose System industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Self-Monitoring Blood Glucose System 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Self-Monitoring Blood Glucose System worldwide and market share by regions, with company and product introduction, position in the Self-Monitoring Blood Glucose System market
Market status and development trend of Self-Monitoring Blood Glucose System by types and applications
Cost and profit status of Self-Monitoring Blood Glucose System, and marketing status
Market growth drivers and challenges
The report segments the global Self-Monitoring Blood Glucose System market as:
Global Self-Monitoring Blood Glucose System Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Self-Monitoring Blood Glucose System Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Blood Glucose meters
Testing strips
Lancets & Lancing Devices
Global Self-Monitoring Blood Glucose System Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Type 2 Diabetes
Type 1 Diabetes
Gestational Diabetes
Global Self-Monitoring Blood Glucose System Market: Manufacturers Segment Analysis (Company and Product introduction, Self-Monitoring Blood Glucose System Sales Volume, Revenue, Price and Gross Margin):
Roche (Switzerland)
Abbott (US)
LifeScan (US)
Ascensia (Switzerland)
Medtronic (Ireland), Dexcom (US)
Ypsomed (Switzerland)
B. Braun (Germany)
Nipro (Japan), Sanofi (France)
ARKRAY (Japan)
Prodigy Diabetes Care (US)
ACON Laboratories (US)
Nova Biomedical (US)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Self-Monitoring Blood Glucose System-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Self-Monitoring Blood Glucose System industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Self-Monitoring Blood Glucose System 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Self-Monitoring Blood Glucose System worldwide and market share by regions, with company and product introduction, position in the Self-Monitoring Blood Glucose System market
Market status and development trend of Self-Monitoring Blood Glucose System by types and applications
Cost and profit status of Self-Monitoring Blood Glucose System, and marketing status
Market growth drivers and challenges
The report segments the global Self-Monitoring Blood Glucose System market as:
Global Self-Monitoring Blood Glucose System Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Self-Monitoring Blood Glucose System Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Blood Glucose meters
Testing strips
Lancets & Lancing Devices
Global Self-Monitoring Blood Glucose System Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Type 2 Diabetes
Type 1 Diabetes
Gestational Diabetes
Global Self-Monitoring Blood Glucose System Market: Manufacturers Segment Analysis (Company and Product introduction, Self-Monitoring Blood Glucose System Sales Volume, Revenue, Price and Gross Margin):
Roche (Switzerland)
Abbott (US)
LifeScan (US)
Ascensia (Switzerland)
Medtronic (Ireland), Dexcom (US)
Ypsomed (Switzerland)
B. Braun (Germany)
Nipro (Japan), Sanofi (France)
ARKRAY (Japan)
Prodigy Diabetes Care (US)
ACON Laboratories (US)
Nova Biomedical (US)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
1.1 Definition of Self-Monitoring Blood Glucose System in This Report
1.2 Commercial Types of Self-Monitoring Blood Glucose System
1.2.1 Blood Glucose meters
1.2.2 Testing strips
1.2.3 Lancets & Lancing Devices
1.3 Downstream Application of Self-Monitoring Blood Glucose System
1.3.1 Type 2 Diabetes
1.3.2 Type 1 Diabetes
1.3.3 Gestational Diabetes
1.4 Development History of Self-Monitoring Blood Glucose System
1.5 Market Status and Trend of Self-Monitoring Blood Glucose System 2013-2023
1.5.1 Global Self-Monitoring Blood Glucose System Market Status and Trend 2013-2023
1.5.2 Regional Self-Monitoring Blood Glucose System Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Self-Monitoring Blood Glucose System 2013-2017
2.2 Sales Market of Self-Monitoring Blood Glucose System by Regions
2.2.1 Sales Volume of Self-Monitoring Blood Glucose System by Regions
2.2.2 Sales Value of Self-Monitoring Blood Glucose System by Regions
2.3 Production Market of Self-Monitoring Blood Glucose System by Regions
2.4 Global Market Forecast of Self-Monitoring Blood Glucose System 2018-2023
2.4.1 Global Market Forecast of Self-Monitoring Blood Glucose System 2018-2023
2.4.2 Market Forecast of Self-Monitoring Blood Glucose System by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Self-Monitoring Blood Glucose System by Types
3.2 Sales Value of Self-Monitoring Blood Glucose System by Types
3.3 Market Forecast of Self-Monitoring Blood Glucose System by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Self-Monitoring Blood Glucose System by Downstream Industry
4.2 Global Market Forecast of Self-Monitoring Blood Glucose System by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Self-Monitoring Blood Glucose System Market Status by Countries
5.1.1 North America Self-Monitoring Blood Glucose System Sales by Countries (2013-2017)
5.1.2 North America Self-Monitoring Blood Glucose System Revenue by Countries (2013-2017)
5.1.3 United States Self-Monitoring Blood Glucose System Market Status (2013-2017)
5.1.4 Canada Self-Monitoring Blood Glucose System Market Status (2013-2017)
5.1.5 Mexico Self-Monitoring Blood Glucose System Market Status (2013-2017)
5.2 North America Self-Monitoring Blood Glucose System Market Status by Manufacturers
5.3 North America Self-Monitoring Blood Glucose System Market Status by Type (2013-2017)
5.3.1 North America Self-Monitoring Blood Glucose System Sales by Type (2013-2017)
5.3.2 North America Self-Monitoring Blood Glucose System Revenue by Type (2013-2017)
5.4 North America Self-Monitoring Blood Glucose System Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Self-Monitoring Blood Glucose System Market Status by Countries
6.1.1 Europe Self-Monitoring Blood Glucose System Sales by Countries (2013-2017)
6.1.2 Europe Self-Monitoring Blood Glucose System Revenue by Countries (2013-2017)
6.1.3 Germany Self-Monitoring Blood Glucose System Market Status (2013-2017)
6.1.4 UK Self-Monitoring Blood Glucose System Market Status (2013-2017)
6.1.5 France Self-Monitoring Blood Glucose System Market Status (2013-2017)
6.1.6 Italy Self-Monitoring Blood Glucose System Market Status (2013-2017)
6.1.7 Russia Self-Monitoring Blood Glucose System Market Status (2013-2017)
6.1.8 Spain Self-Monitoring Blood Glucose System Market Status (2013-2017)
6.1.9 Benelux Self-Monitoring Blood Glucose System Market Status (2013-2017)
6.2 Europe Self-Monitoring Blood Glucose System Market Status by Manufacturers
6.3 Europe Self-Monitoring Blood Glucose System Market Status by Type (2013-2017)
6.3.1 Europe Self-Monitoring Blood Glucose System Sales by Type (2013-2017)
6.3.2 Europe Self-Monitoring Blood Glucose System Revenue by Type (2013-2017)
6.4 Europe Self-Monitoring Blood Glucose System Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Self-Monitoring Blood Glucose System Market Status by Countries
7.1.1 Asia Pacific Self-Monitoring Blood Glucose System Sales by Countries (2013-2017)
7.1.2 Asia Pacific Self-Monitoring Blood Glucose System Revenue by Countries (2013-2017)
7.1.3 China Self-Monitoring Blood Glucose System Market Status (2013-2017)
7.1.4 Japan Self-Monitoring Blood Glucose System Market Status (2013-2017)
7.1.5 India Self-Monitoring Blood Glucose System Market Status (2013-2017)
7.1.6 Southeast Asia Self-Monitoring Blood Glucose System Market Status (2013-2017)
7.1.7 Australia Self-Monitoring Blood Glucose System Market Status (2013-2017)
7.2 Asia Pacific Self-Monitoring Blood Glucose System Market Status by Manufacturers
7.3 Asia Pacific Self-Monitoring Blood Glucose System Market Status by Type (2013-2017)
7.3.1 Asia Pacific Self-Monitoring Blood Glucose System Sales by Type (2013-2017)
7.3.2 Asia Pacific Self-Monitoring Blood Glucose System Revenue by Type (2013-2017)
7.4 Asia Pacific Self-Monitoring Blood Glucose System Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Self-Monitoring Blood Glucose System Market Status by Countries
8.1.1 Latin America Self-Monitoring Blood Glucose System Sales by Countries (2013-2017)
8.1.2 Latin America Self-Monitoring Blood Glucose System Revenue by Countries (2013-2017)
8.1.3 Brazil Self-Monitoring Blood Glucose System Market Status (2013-2017)
8.1.4 Argentina Self-Monitoring Blood Glucose System Market Status (2013-2017)
8.1.5 Colombia Self-Monitoring Blood Glucose System Market Status (2013-2017)
8.2 Latin America Self-Monitoring Blood Glucose System Market Status by Manufacturers
8.3 Latin America Self-Monitoring Blood Glucose System Market Status by Type (2013-2017)
8.3.1 Latin America Self-Monitoring Blood Glucose System Sales by Type (2013-2017)
8.3.2 Latin America Self-Monitoring Blood Glucose System Revenue by Type (2013-2017)
8.4 Latin America Self-Monitoring Blood Glucose System Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Self-Monitoring Blood Glucose System Market Status by Countries
9.1.1 Middle East and Africa Self-Monitoring Blood Glucose System Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Self-Monitoring Blood Glucose System Revenue by Countries (2013-2017)
9.1.3 Middle East Self-Monitoring Blood Glucose System Market Status (2013-2017)
9.1.4 Africa Self-Monitoring Blood Glucose System Market Status (2013-2017)
9.2 Middle East and Africa Self-Monitoring Blood Glucose System Market Status by Manufacturers
9.3 Middle East and Africa Self-Monitoring Blood Glucose System Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Self-Monitoring Blood Glucose System Sales by Type (2013-2017)
9.3.2 Middle East and Africa Self-Monitoring Blood Glucose System Revenue by Type (2013-2017)
9.4 Middle East and Africa Self-Monitoring Blood Glucose System Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
10.1 Global Economy Situation and Trend Overview
10.2 Self-Monitoring Blood Glucose System Downstream Industry Situation and Trend Overview
CHAPTER 11 SELF-MONITORING BLOOD GLUCOSE SYSTEM MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Self-Monitoring Blood Glucose System by Major Manufacturers
11.2 Production Value of Self-Monitoring Blood Glucose System by Major Manufacturers
11.3 Basic Information of Self-Monitoring Blood Glucose System by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Self-Monitoring Blood Glucose System Major Manufacturer
11.3.2 Employees and Revenue Level of Self-Monitoring Blood Glucose System Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 SELF-MONITORING BLOOD GLUCOSE SYSTEM MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Roche (Switzerland)
12.1.1 Company profile
12.1.2 Representative Self-Monitoring Blood Glucose System Product
12.1.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Roche (Switzerland)
12.2 Abbott (US)
12.2.1 Company profile
12.2.2 Representative Self-Monitoring Blood Glucose System Product
12.2.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Abbott (US)
12.3 LifeScan (US)
12.3.1 Company profile
12.3.2 Representative Self-Monitoring Blood Glucose System Product
12.3.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of LifeScan (US)
12.4 Ascensia (Switzerland)
12.4.1 Company profile
12.4.2 Representative Self-Monitoring Blood Glucose System Product
12.4.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Ascensia (Switzerland)
12.5 Medtronic (Ireland), Dexcom (US)
12.5.1 Company profile
12.5.2 Representative Self-Monitoring Blood Glucose System Product
12.5.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Medtronic (Ireland), Dexcom (US)
12.6 Ypsomed (Switzerland)
12.6.1 Company profile
12.6.2 Representative Self-Monitoring Blood Glucose System Product
12.6.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Ypsomed (Switzerland)
12.7 B. Braun (Germany)
12.7.1 Company profile
12.7.2 Representative Self-Monitoring Blood Glucose System Product
12.7.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of B. Braun (Germany)
12.8 Nipro (Japan), Sanofi (France)
12.8.1 Company profile
12.8.2 Representative Self-Monitoring Blood Glucose System Product
12.8.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Nipro (Japan), Sanofi (France)
12.9 ARKRAY (Japan)
12.9.1 Company profile
12.9.2 Representative Self-Monitoring Blood Glucose System Product
12.9.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of ARKRAY (Japan)
12.10 Prodigy Diabetes Care (US)
12.10.1 Company profile
12.10.2 Representative Self-Monitoring Blood Glucose System Product
12.10.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Prodigy Diabetes Care (US)
12.11 ACON Laboratories (US)
12.11.1 Company profile
12.11.2 Representative Self-Monitoring Blood Glucose System Product
12.11.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of ACON Laboratories (US)
12.12 Nova Biomedical (US)
12.12.1 Company profile
12.12.2 Representative Self-Monitoring Blood Glucose System Product
12.12.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Nova Biomedical (US)
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
13.1 Industry Chain of Self-Monitoring Blood Glucose System
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
14.1 Cost Structure Analysis of Self-Monitoring Blood Glucose System
14.2 Raw Materials Cost Analysis of Self-Monitoring Blood Glucose System
14.3 Labor Cost Analysis of Self-Monitoring Blood Glucose System
14.4 Manufacturing Expenses Analysis of Self-Monitoring Blood Glucose System
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Self-Monitoring Blood Glucose System in This Report
1.2 Commercial Types of Self-Monitoring Blood Glucose System
1.2.1 Blood Glucose meters
1.2.2 Testing strips
1.2.3 Lancets & Lancing Devices
1.3 Downstream Application of Self-Monitoring Blood Glucose System
1.3.1 Type 2 Diabetes
1.3.2 Type 1 Diabetes
1.3.3 Gestational Diabetes
1.4 Development History of Self-Monitoring Blood Glucose System
1.5 Market Status and Trend of Self-Monitoring Blood Glucose System 2013-2023
1.5.1 Global Self-Monitoring Blood Glucose System Market Status and Trend 2013-2023
1.5.2 Regional Self-Monitoring Blood Glucose System Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Self-Monitoring Blood Glucose System 2013-2017
2.2 Sales Market of Self-Monitoring Blood Glucose System by Regions
2.2.1 Sales Volume of Self-Monitoring Blood Glucose System by Regions
2.2.2 Sales Value of Self-Monitoring Blood Glucose System by Regions
2.3 Production Market of Self-Monitoring Blood Glucose System by Regions
2.4 Global Market Forecast of Self-Monitoring Blood Glucose System 2018-2023
2.4.1 Global Market Forecast of Self-Monitoring Blood Glucose System 2018-2023
2.4.2 Market Forecast of Self-Monitoring Blood Glucose System by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Self-Monitoring Blood Glucose System by Types
3.2 Sales Value of Self-Monitoring Blood Glucose System by Types
3.3 Market Forecast of Self-Monitoring Blood Glucose System by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Self-Monitoring Blood Glucose System by Downstream Industry
4.2 Global Market Forecast of Self-Monitoring Blood Glucose System by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Self-Monitoring Blood Glucose System Market Status by Countries
5.1.1 North America Self-Monitoring Blood Glucose System Sales by Countries (2013-2017)
5.1.2 North America Self-Monitoring Blood Glucose System Revenue by Countries (2013-2017)
5.1.3 United States Self-Monitoring Blood Glucose System Market Status (2013-2017)
5.1.4 Canada Self-Monitoring Blood Glucose System Market Status (2013-2017)
5.1.5 Mexico Self-Monitoring Blood Glucose System Market Status (2013-2017)
5.2 North America Self-Monitoring Blood Glucose System Market Status by Manufacturers
5.3 North America Self-Monitoring Blood Glucose System Market Status by Type (2013-2017)
5.3.1 North America Self-Monitoring Blood Glucose System Sales by Type (2013-2017)
5.3.2 North America Self-Monitoring Blood Glucose System Revenue by Type (2013-2017)
5.4 North America Self-Monitoring Blood Glucose System Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Self-Monitoring Blood Glucose System Market Status by Countries
6.1.1 Europe Self-Monitoring Blood Glucose System Sales by Countries (2013-2017)
6.1.2 Europe Self-Monitoring Blood Glucose System Revenue by Countries (2013-2017)
6.1.3 Germany Self-Monitoring Blood Glucose System Market Status (2013-2017)
6.1.4 UK Self-Monitoring Blood Glucose System Market Status (2013-2017)
6.1.5 France Self-Monitoring Blood Glucose System Market Status (2013-2017)
6.1.6 Italy Self-Monitoring Blood Glucose System Market Status (2013-2017)
6.1.7 Russia Self-Monitoring Blood Glucose System Market Status (2013-2017)
6.1.8 Spain Self-Monitoring Blood Glucose System Market Status (2013-2017)
6.1.9 Benelux Self-Monitoring Blood Glucose System Market Status (2013-2017)
6.2 Europe Self-Monitoring Blood Glucose System Market Status by Manufacturers
6.3 Europe Self-Monitoring Blood Glucose System Market Status by Type (2013-2017)
6.3.1 Europe Self-Monitoring Blood Glucose System Sales by Type (2013-2017)
6.3.2 Europe Self-Monitoring Blood Glucose System Revenue by Type (2013-2017)
6.4 Europe Self-Monitoring Blood Glucose System Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Self-Monitoring Blood Glucose System Market Status by Countries
7.1.1 Asia Pacific Self-Monitoring Blood Glucose System Sales by Countries (2013-2017)
7.1.2 Asia Pacific Self-Monitoring Blood Glucose System Revenue by Countries (2013-2017)
7.1.3 China Self-Monitoring Blood Glucose System Market Status (2013-2017)
7.1.4 Japan Self-Monitoring Blood Glucose System Market Status (2013-2017)
7.1.5 India Self-Monitoring Blood Glucose System Market Status (2013-2017)
7.1.6 Southeast Asia Self-Monitoring Blood Glucose System Market Status (2013-2017)
7.1.7 Australia Self-Monitoring Blood Glucose System Market Status (2013-2017)
7.2 Asia Pacific Self-Monitoring Blood Glucose System Market Status by Manufacturers
7.3 Asia Pacific Self-Monitoring Blood Glucose System Market Status by Type (2013-2017)
7.3.1 Asia Pacific Self-Monitoring Blood Glucose System Sales by Type (2013-2017)
7.3.2 Asia Pacific Self-Monitoring Blood Glucose System Revenue by Type (2013-2017)
7.4 Asia Pacific Self-Monitoring Blood Glucose System Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Self-Monitoring Blood Glucose System Market Status by Countries
8.1.1 Latin America Self-Monitoring Blood Glucose System Sales by Countries (2013-2017)
8.1.2 Latin America Self-Monitoring Blood Glucose System Revenue by Countries (2013-2017)
8.1.3 Brazil Self-Monitoring Blood Glucose System Market Status (2013-2017)
8.1.4 Argentina Self-Monitoring Blood Glucose System Market Status (2013-2017)
8.1.5 Colombia Self-Monitoring Blood Glucose System Market Status (2013-2017)
8.2 Latin America Self-Monitoring Blood Glucose System Market Status by Manufacturers
8.3 Latin America Self-Monitoring Blood Glucose System Market Status by Type (2013-2017)
8.3.1 Latin America Self-Monitoring Blood Glucose System Sales by Type (2013-2017)
8.3.2 Latin America Self-Monitoring Blood Glucose System Revenue by Type (2013-2017)
8.4 Latin America Self-Monitoring Blood Glucose System Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Self-Monitoring Blood Glucose System Market Status by Countries
9.1.1 Middle East and Africa Self-Monitoring Blood Glucose System Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Self-Monitoring Blood Glucose System Revenue by Countries (2013-2017)
9.1.3 Middle East Self-Monitoring Blood Glucose System Market Status (2013-2017)
9.1.4 Africa Self-Monitoring Blood Glucose System Market Status (2013-2017)
9.2 Middle East and Africa Self-Monitoring Blood Glucose System Market Status by Manufacturers
9.3 Middle East and Africa Self-Monitoring Blood Glucose System Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Self-Monitoring Blood Glucose System Sales by Type (2013-2017)
9.3.2 Middle East and Africa Self-Monitoring Blood Glucose System Revenue by Type (2013-2017)
9.4 Middle East and Africa Self-Monitoring Blood Glucose System Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
10.1 Global Economy Situation and Trend Overview
10.2 Self-Monitoring Blood Glucose System Downstream Industry Situation and Trend Overview
CHAPTER 11 SELF-MONITORING BLOOD GLUCOSE SYSTEM MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Self-Monitoring Blood Glucose System by Major Manufacturers
11.2 Production Value of Self-Monitoring Blood Glucose System by Major Manufacturers
11.3 Basic Information of Self-Monitoring Blood Glucose System by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Self-Monitoring Blood Glucose System Major Manufacturer
11.3.2 Employees and Revenue Level of Self-Monitoring Blood Glucose System Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 SELF-MONITORING BLOOD GLUCOSE SYSTEM MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Roche (Switzerland)
12.1.1 Company profile
12.1.2 Representative Self-Monitoring Blood Glucose System Product
12.1.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Roche (Switzerland)
12.2 Abbott (US)
12.2.1 Company profile
12.2.2 Representative Self-Monitoring Blood Glucose System Product
12.2.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Abbott (US)
12.3 LifeScan (US)
12.3.1 Company profile
12.3.2 Representative Self-Monitoring Blood Glucose System Product
12.3.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of LifeScan (US)
12.4 Ascensia (Switzerland)
12.4.1 Company profile
12.4.2 Representative Self-Monitoring Blood Glucose System Product
12.4.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Ascensia (Switzerland)
12.5 Medtronic (Ireland), Dexcom (US)
12.5.1 Company profile
12.5.2 Representative Self-Monitoring Blood Glucose System Product
12.5.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Medtronic (Ireland), Dexcom (US)
12.6 Ypsomed (Switzerland)
12.6.1 Company profile
12.6.2 Representative Self-Monitoring Blood Glucose System Product
12.6.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Ypsomed (Switzerland)
12.7 B. Braun (Germany)
12.7.1 Company profile
12.7.2 Representative Self-Monitoring Blood Glucose System Product
12.7.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of B. Braun (Germany)
12.8 Nipro (Japan), Sanofi (France)
12.8.1 Company profile
12.8.2 Representative Self-Monitoring Blood Glucose System Product
12.8.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Nipro (Japan), Sanofi (France)
12.9 ARKRAY (Japan)
12.9.1 Company profile
12.9.2 Representative Self-Monitoring Blood Glucose System Product
12.9.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of ARKRAY (Japan)
12.10 Prodigy Diabetes Care (US)
12.10.1 Company profile
12.10.2 Representative Self-Monitoring Blood Glucose System Product
12.10.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Prodigy Diabetes Care (US)
12.11 ACON Laboratories (US)
12.11.1 Company profile
12.11.2 Representative Self-Monitoring Blood Glucose System Product
12.11.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of ACON Laboratories (US)
12.12 Nova Biomedical (US)
12.12.1 Company profile
12.12.2 Representative Self-Monitoring Blood Glucose System Product
12.12.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Nova Biomedical (US)
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
13.1 Industry Chain of Self-Monitoring Blood Glucose System
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
14.1 Cost Structure Analysis of Self-Monitoring Blood Glucose System
14.2 Raw Materials Cost Analysis of Self-Monitoring Blood Glucose System
14.3 Labor Cost Analysis of Self-Monitoring Blood Glucose System
14.4 Manufacturing Expenses Analysis of Self-Monitoring Blood Glucose System
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
